Shuttle Pharmaceuticals Inc Strategic Asset Allocation Index
Shuttle Pharmaceuticals Inc strategic asset allocation index. Shuttle Pharmaceuticals Inc (SHPH) has a Strategic Asset Allocation Index of 0.7% as of March 2023. Strategic assets (PP&E of $50.93K plus long-term investments of $-) total $50.93K, measured against net assets of $6.91 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See SHPH net asset quality score to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Shuttle Pharmaceuticals Inc (2018–2022)
Strategic asset allocation index of Shuttle Pharmaceuticals Inc from 2018 to 2022. This chart shows how Shuttle Pharmaceuticals Inc's Strategic Asset Allocation Index has evolved across 2 annual periods from 2018 to 2022. As of March 2023, the index stands at 0.7%, representing strategic assets of $50.93K against net assets of $6.91 Million USD. Check SHPH tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Shuttle Pharmaceuticals Inc Strategic Asset Allocation Index by Year (2018–2022)
Shuttle Pharmaceuticals Inc strategic asset allocation index by year from 2018 to 2022. The table below presents the year-by-year Strategic Asset Allocation Index for Shuttle Pharmaceuticals Inc from 2018 to 2022, covering 2 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Shuttle Pharmaceuticals Inc (SHPH) market capitalisation.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 0.9% | $68.71K | $68.71K | $- | $7.68 Million | ▼ -2.2 pp |
| 2018 | 3.1% | $838.00 | $838.00 | $- | $27.46K | — |